Advances in the Transformation to Small Cell Lung Cancer from Non-small Cell Lung Cancer Following Acquired Drug-resistance to EGFR Tyrosine Kinase Inhibitors

Advances in the Transformation to Small Cell Lung Cancer from Non-small Cell Lung Cancer Following Acquired Drug-resistance to EGFR Tyrosine Kinase Inhibitors

The use of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in the treatment of sensitive EGFR mutation in non-small cell lung cancer (NSCLC) has been proved significant curative effect. However, the acquisition of the drug resistance to EGFR-TKIs is almost inevitable, and com...

Full description

Bibliographic Details
Main Authors: Wenqiu ZHANG, Yongqi LI, Di WU
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2017-10-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Epidermal growth factor receptor tyrosine kinase inhibitor
Drug resistance
Mechanism
Transformation
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2017.10.10

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2017.10.10

Similar Items